Onconetix, Inc. Preferred Stock Convertible Shares Issuable
Onconetix, Inc. (ONCO) had Preferred Stock Convertible Shares Issuable of 3.00 thousand shares as of 2024-09-24, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures › Features of Convertible Preferred Stock
us-gaap:PreferredStockConvertibleSharesIssuable · last filed 2026-08-13
- 2024-09-24: Preferred Stock Convertible Shares Issuable 3.00K shares.
- 2024-06-30: Preferred Stock Convertible Shares Issuable 5.71M shares.
- 2024-03-31: Preferred Stock Convertible Shares Issuable 5.71M shares.
- 2023-12-31: Preferred Stock Convertible Shares Issuable 5.71M shares.
| Period end | Preferred Stock Convertible Shares Issuable |
|---|---|
| 2024-09-24 | 3.00K shares 10-Q · filed 2026-08-13 |
| 2024-06-30 | 5.71M shares 10-Q · filed 2024-08-29 |
| 2024-03-31 | 5.71M shares 10-Q · filed 2024-05-20 |
| 2023-12-31 | 5.71M shares 10-K · filed 2024-04-11 |
| 2023-12-15 | 2.70M shares 10-Q · filed 2024-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |